
Sunil Krishnan
Professor and John P. and Kathrine G. McGovern Distinguished Chair, Neurosciences · University of Texas Health Science Center at Houston
Credentials: · · · · ·
History
PresentNeurosciences Department · University of Texas Health Science Center at Houston
PresentTherapeutics and Pharmacology Graduate Program · University of Texas Health Science Center at Houston

Hematology and Medical Oncology
Penn State Geisinger Medical Center

Research
PDL1 Regulation by p53 via miR-34
Journal of the National Cancer Institute · 2016 · 592 citations
Cancer Research · 2007 · 486 citations
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma
Annals of Surgical Oncology · 2009 · 400 citations

77 papers

Christopher Crane
74 papers

42 papers

33 papers

30 papers

29 papers
- JS
28 papers

27 papers
Grants
- 2022–2027
National Cancer Institute · R01
PI · $3M · University of Tx Md Anderson Can Ctr
- 2021–2026
Rational Translation of Gold Nanoparticle Mediated Radiosensitization to the Clinic
National Cancer Institute · R01
Contact PI · $3.1M · University of Texas Hlth Sci Ctr Houston
- 2019–2024
Enhancing Immune Mediated Head and Neck Cancer Anti-Tumor Activity Using Nanoparticles
National Institute of Dental and Craniofacial Research · R01
Contact PI · $2.4M · University of Texas Hlth Sci Ctr Houston
- 2017–2024
Enhancing Chemoradiation Efficacy Through Unbiased Drug Discovery Approaches
National Cancer Institute · U01
PI · $2.9M · University of Tx Md Anderson Can Ctr
Clinical trials
- 2009–2010
Vorinostat Plus Radiation Therapy in Pancreatic Cancer
Principal investigator · Terminated · Phase 1, Phase 2
M.D. Anderson Cancer Center
- 2008–2016
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center
- 2007–2009
Proton Therapy and Bevacizumab for Primary Liver Tumors
Principal investigator · Terminated · Phase 1
M.D. Anderson Cancer Center

